PSU PRESS RELEASE
NRDC inks Technology Commercialization Agreement for AYUSH
New Delhi. NRDC inks Technology Commercialization Agreement for AYUSH-82; AYUSH SG and Herbal Formulation for Anti-Arthritis Dr. H. Purushotham CMD, National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Govt. of India,New Delhi .
Informed through the press release that NRDC and M/s Ridhi Sidhi Medicare, New Delhi have entered into License Agreements for commercialization of AYUSH-82, an ayurvedic formulation for management of Diabetes, Ayush–S.G for Rheumatoid Arthritis and Herbal Formulation for Anti- Arthritis.
Read Also : Air Chief Marshal VR Chaudhari, CAS presented Presidential Awards to 51 IAF personnel
News Must Read
- NCL General Manager (Finance) D Sunil Kumar recommended for SECL Director (Finance)
- Bank of Maharashtra Q4 results, Net Profit increased by 44.95 percent to Rs 1,218 crore
- Axis Bank Overtakes Kotak Mahindra Bank to Become India's Fourth Most Valued Lender
- LIC cuts stakes in major PSU stocks
- SJVN CMD Geeta Kapur Inaugurates Construction Works at Sunni Dam Project in Himachal Pradesh
- PESB Selects R Veerabahu as Director (Finance) for Braithwaite & Co. Limited
- Grew Energy bags largest order of 200 MW Contract of SECI's Auction
- CPCL Reports 39% YoY Drop in Q4 Net Profit, Declares Rs 55 per Share Dividend
- SJVN Limited inaugurates India's first Multi-purpose Green Hydrogen Pilot Project
- KRDCL, RVNL JV emerges as the Lowest Bidder for Redevelopment of Thiruvananthapuram Central Railway Station